F. Mornex

发表

Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists.

B. Dubray, I. Lazarescu, M. Joulakian, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Impact of neoadjuvant chemoradiation on lymph node status in esophageal cancer: post hoc analysis of a randomized controlled trial.

J. Bosset, C. Mariette, J. Triboulet, 2015, Annals of surgery.

Histopathological Response to Preoperative Chemoradiation for Resectable Pancreatic Adenocarcinoma: The French Phase II FFCD 9704-SFRO Trial

M. Ychou, J. Scoazec, F. Mornex, 2008, American journal of clinical oncology.

Late effects toxicity scoring: the SOMA scale

Jacques Bernier, Michel Bolla, Juliana Denekamp, 1995 .

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.

T. Conroy, M. Ducreux, D. Peiffert, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

XIAP as a radioresistance factor and prognostic marker for radiotherapy in human rectal adenocarcinoma.

S. Hehlgans, F. Rödel, B. Flourié, 2012, The American journal of pathology.

Immunosuppression and hepatocellular carcinoma

J. Trotter, H. Schlitt, A. Shaked, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies

Thomas Henzler, Rozemarijn Vliegenthart, Lucio Crino, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update].

N. Girard, F. Mornex, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial☆

Sébastien Clippe, Christophe Hennequin, André Pèlegrin, 2015, EBioMedicine.

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial

C. Bourgier, C. Hennequin, F. Mornex, 2018, Oncotarget.

Single Nucleotide Polymorphisms, Apoptosis, and the Development of Severe Late Adverse Effects After Radiotherapy

R. Mirimanoff, M. Ozsahin, N. Crompton, 2008, Clinical Cancer Research.

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.

L. Thiberville, P. Souquet, P. Fournel, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.

Joe Y. Chang, A. Bezjak, F. Mornex, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non-Small-Cell Lung Cancer

Joe Y. Chang, A. Bezjak, F. Mornex, 2015 .

Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.

L. Quéro, T. Conroy, C. Borg, 2019, Clinical colorectal cancer.

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.

B. Chauffert, J. Bosset, P. Maingon, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[Stereotactic body radiotherapy for liver tumors: State of the art].

F. Mornex, O. Riou, D. Azria, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of acute toxicities in a French centre and a review of the literature].

B. De Bari, F. Mornex, O. Chapet, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Multidisciplinary Lung Cancer Meetings: Improving the practice of radiation oncology and facing future challenges

D. Ball, F. Mornex, B. Campbell, 2015, Respirology.

Lung metastases radiation therapy

F. Mornex, S. Thureau, J. Darréon, 2021, Cancer/Radiothérapie.

Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus

J. Gérard, F. Mornex, M. Adham, 2000, Cancer.

The clinical implications of gemcitabine radiosensitization.

W. Mckenna, F. Mornex, T. C. Doyle, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[Radiotherapy of lung cancer: Any room left for elective mediastinal irradiation in 2011?].

P. van Houtte, F. Mornex, M. Roelandts, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Normal tissue tolerance to external beam radiation therapy: lung].

F. Mornex, C. Ortholan, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Small Cell Lung Cancer: Limited Disease

P. Houtte, F. Mornex, M. Roelandts, 2004 .

Toxicity of combined radiation and chemotherapy in non-small cell lung cancer.

P. van Houtte, F. Mornex, S. Danhier, 1994, Lung cancer.

Volume tumoral macroscopique et volume–cible anatomoclinique en radiothérapie : cancer bronchique

P. Giraud, F. Mornex, O. Chapet, 2001 .

Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial.

P. Romestaing, J. Gérard, F. Mornex, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatic tumours and radiotherapy.

P. Maingon, F. Mornex, L. Parent, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Hepatic tumors and radiotherapy].

D. Peiffert, F. Mornex, E. Rio, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)

E. Itti, S. Bardet, P. Olivier, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Cancer of the pancreas.

Y. Bécouarn, P. Hammel, F. Mornex, 2006, Gastroenterologie clinique et biologique.

Staging classification committee.

J. Jett, R. Ginsberg, R. Tsuchiya, 1997, Lung cancer.

Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives

F. Mornex, D. Antoni, 2016, Current opinion in oncology.

Induction therapy for NSCLC: a consensus report

R. Mirimanoff, R. Ginsberg, A. Gregor, 1991 .

Standard-fractionated radiotherapy for optic nerve sheath meningioma: visual outcome is predicted by mean eye dose.

N. Girard, A. Vighetto, C. Tilikete, 2012, International journal of radiation oncology, biology, physics.

Late effects consensus conference: RTOG/EORTC.

H. Bartelink, J. Horiot, T. Phillips, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?

P. Romestaing, J. Gérard, F. Mornex, 2005, International journal of radiation oncology, biology, physics.

Neoadjuvant conformal radiotherapy before liver transplantation for hepatocellular carcinoma: a propensity score matched analysis of postoperative morbidity and oncological results.

M. Lesurtel, F. Mornex, J. Mabrut, 2019, Future oncology.

Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment.

N. Girard, F. Mornex, J. Delpero, 2005, Seminars in radiation oncology.

The role of radiotherapy in the management of thymic tumors.

N. Girard, F. Mornex, 2011, Thoracic surgery clinics.

Thymoma: a focus on current therapeutic management.

N. Girard, P. V. Van Schil, P. van Houtte, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Markedly effective local control of hepatocellular carcinoma with a poor prognosis by combined multimodal therapy with sorafenib as a neoadjuvant approach.

F. Zoulim, F. Mornex, F. Bathaix, 2010, Gastroenterologie clinique et biologique.

Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT).

F. Chauvin, P. Romestaing, P. Fournel, 1993, Lung cancer.

Radiotherapy of high bile duct carcinoma using intracatheter iridium 192 wire

J. Gérard, F. Mornex, P. Bret, 1984, Cancer.

Intracerebral C6 glioma model in female hairless rats: assessment by using MRI and follow-up of irradiation.

A. Jouvet, A. Bonmartin, F. Mornex, 2003, Anticancer research.

Radiation Therapy for Malignant Astrocytomas in Adults

F. Mornex, L. Taillandier, H. Nayel, 1994 .

Monoclonal Antibodies in the Management of Breast Cancer

J. Schlom, F. Mornex, D. Colcher, 1986 .

Radioimmunodetection of human colon carcinoma xenografts in visceral organs of congenitally athymic mice

J. Lundy, F. Mornex, J. Greiner, 1986, Cancer.

EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale.

H. Bartelink, J. Horiot, M. Bolla, 1995, International journal of radiation oncology, biology, physics.

Physician Bias in Prophylactic Cranial Irradiation Decision Making—An Opportunity for a Patient Decision Aid

F. Hirsch, L. Gaspar, F. Kong, 2018, Clinical lung cancer.

Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).

N. Girard, A. Stenzinger, C. Swanton, 2019 .

Tissue distribution and stability of metalloporphyrin MRI contrast agents

S. H. Koenig, J. S. Cohen, F. Mornex, 1987, Magnetic resonance in medicine.

Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901.

J. Bosset, C. Mariette, J. Triboulet, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma].

A. Hauschild, F. Mornex, B. Nguyen, 2003, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma

A. Hauschild, B. Bui, F. Mornex, 2003, Melanoma research.

[Providing information to patients].

F. Mornex, 2000, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice.

A. Dwyer, R. Knop, N. Patronas, 1986, Cancer treatment reports.

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study

J. Tepper, L. Kachnic, L. Case, 2006, British Journal of Cancer.

C. Swanton, U. Dafni, D. de Ruysscher, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomas

P. Biron, F. Mornex, C. Ardiet, 2004, Cancer Chemotherapy and Pharmacology.

Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.

F. Cappuzzo, D. de Ruysscher, S. Novello, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.

F. Cappuzzo, D. de Ruysscher, S. Novello, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.

T. Petit, P. Quétin, P. Romestaing, 2007, Gynecologic oncology.

Adjuvant chemotherapy alone versus chemoradiation after curative resection for pancreatic cancer : feasibility results of a randomised EORTC/FFCD/GERCOR phase II/III study (40013/22012/0304)

V. Budach, K. Haustermans, G. Tienhoven, 2008 .

Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: a non-comparative randomized phase II trial.

J. Pignon, T. Conroy, M. Ducreux, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].

B. Chauffert, P. Maingon, P. Rougier, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review.

N. Girard, C. Hennequin, F. Mornex, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential versus concurrent chemo-radiation (RT-CT) in locally advanced non small cell lung cancer (NSCLC): A French randomized phase III trial of GLOT-GFPC (NPC 95-01 study)

J. Daurès, P. Souquet, P. Fournel, 2001 .

Preoperative concurrent chemoradiation in locally advanced rectal cancer with 50 Gy and oxaliplatin (OXA), fluorouracil (FU), I-folinic acid (l-LV). The lyon R0-04 phase II trial

P. Romestaing, J. Gérard, F. Mornex, 2002 .

A pathologic complete response in the surgical specimen after systemic chemotherapy for a gallbladder carcinoma.

E. Cotte, J. Saurin, B. Flourié, 2012, Gastrointestinal cancer research : GCR.

Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: Analysis of a randomized controlled phase III trial FFCD 9901.

C. Mariette, V. Boige, D. Pezet, 2010 .

[Chemoradiation for pancreatic adenocarcinoma].

L. Claude, F. Mornex, C. Partensky, 2004, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.

F. Mornex, N. Chouaki, K. Peignaux, 2013, Lung cancer.

[Preoperative radiotherapy of rectal cancer. The Lyons experience, 1985-1996. Prognostic study apropos of 312 patients].

E. Morignat, P. Romestaing, J. Gérard, 1999, Annales de chirurgie.

Patterns of recurrence in early‐stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone

C. Mariette, J. Triboulet, F. Mornex, 2015, The British journal of surgery.

Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC). Groupe Lyonnais d'Oncologie Thoracique.

F. Chauvin, P. Romestaing, P. Fournel, 1990, International journal of radiation oncology, biology, physics.

Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Series of 30 Patients Collected From 3 Institutions

D. Jaeck, J. Scoazec, J. Mosnier, 2008, Pancreas.

Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.

P. Rambert, F. Mornex, X. Mirabel, 1995, International journal of radiation oncology, biology, physics.

Curative external beam radiotherapy for prostate carcinoma: results in 231 patients treated in Lyon.

P. Romestaing, J. Gérard, F. Mornex, 1999, The Australian and New Zealand journal of surgery.

40e réunion de l'American Society for Therapeutic Radiology and Oncology Phoenix (Arizona), 25–29 octobre 1998

G. Calais, J. Bachaud, E. Lartigau, 1999 .

Differential effects of ionizing radiation and platinum-derivative chemotherapy on apoptotic pathways in testicular germ cells

M. Benahmed, C. Mauduit, P. Romestaing, 2007, International journal of radiation biology.

Single Nucleotide Polymorphisms, Apoptosis and the Development of Severe Late Adverse Effects Following Radiotherapy

M. Ozsahin, N. Crompton, B. Rosenstein, 2008 .

Feasibility of preoperative and postoperative chemoradiotherapy in gastric adenocarcinoma. Two phase II studies done in parallel. Fédération Francophone de Cancérologie Digestive 0308.

I. Sobhani, B. Dousset, D. Péré-Vergé, 2014, European journal of cancer.

Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of toxicities in a French center.

J. Gérard, F. Mornex, O. Chapet, 2011, Journal of clinical gastroenterology.

[Hypofractionation and radiotherapy: "the eternal return"].

F. Eschwège, J. Cosset, F. Mornex, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Stereotactic ablative irradiation for lung cancer].

F. Mornex, G. Noël, D. Antoni, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiotherapy for patient with cardiac implantable electronic device, consensus from French radiation oncology society.

Cyrus Chargari, É. Marijon, T. Lacornerie, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: histological and autoradiographic study of effects on tumors and normal organs.

J. Schlom, F. Mornex, D. Colcher, 1987, European journal of cancer & clinical oncology.

[Stereotactic radiotherapy in brain metastases].

N. Reyns, F. Mornex, P. Metellus, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Treatment Characteristics and Real-World Progression-Free Survival in Patients with Unresectable Stage III NSCLC who Received Durvalumab After Chemoradiotherapy: Findings from the PACIFIC-R Study.

N. Girard, R. Fietkau, B. Markman, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Normal tissue tolerance to external beam radiation therapy: liver].

B. De Bari, F. Mornex, X. Mirabel, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Management of inguinal lymph node metastases in patients with carcinoma of the anal canal

E. Morignat, P. Romestaing, J. Gérard, 2001, Cancer.

Prognostic factors of squamous cell carcinoma of the anal margin treated by radiotherapy: the Lyon experience

P. Romestaing, J. Gérard, F. Mornex, 2006, International Journal of Colorectal Disease.

LATE EFFECTS TOXICITY SCORING : THE SOMA SCALE

H. Bartelink, J. Horiot, M. Bolla, 1995 .

Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival

J. Pignon, M. Ychou, M. Ducreux, 2011, Radiation oncology.

Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.

P. Adeleine, P. Romestaing, J. Gérard, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: A FFCD-SFRO study.

B. Chauffert, J. Bosset, P. Rougier, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer

B. Loo, J. Thariat, U. Ricardi, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Advances in Radiotherapy for Locally Advanced NSCLC

J. Thariat, F. Mornex, A. Lapierre, 2015 .

Highlights of the 2nd European Lung Cancer Conference

N. Girard, F. Mornex, 2010, Expert review of anticancer therapy.

Role of radiation therapy in the treatment of primary tracheal carcinoma.

P. van Houtte, P. Maingon, F. Mornex, 1998, International journal of radiation oncology, biology, physics.

Cardiac tamponade during esophagoscopy.

P. Bachmann, F. Mornex, F. Desseigne, 1996, Endoscopy.

Innovative therapy for hepatocellular carcinoma: three-dimensional high-dose photon radiotherapy.

C. Trépo, F. Mornex, P. Merle, 2009, Cancer letters.

Radiotherapy for Hepatocellular Carcinoma: An Overview

L. Dawson, Y. Akine, J. Seong, 2008, Annals of Surgical Oncology.

Efficacy and safety of transarterial chemoembolization combined to conformal radiotherapy for uninodular hepatocellular carcinoma

F. Mornex, F. Bathaix, P. Merle, 2014 .

Stereotactic body radiation therapy for liver tumors.

P. Maingon, F. Mornex, G. Créhange, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Efficacy andsafety oftransarterialchemoembolization combined toconformal radiotherapy foruninodularhepatocellular carcinoma

F. Mornex, F. Bathaix, P. Merle, 2014 .

The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC

E. Smit, Yi-long Wu, M. Papotti, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Primary liver cancer].

James V. Leonard, A. L. Wong, I. Módy, 1989, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Do We Have the Real Tools to Evaluate Lung Radiotoxicity

L. Boersma, F. Mornex, 1999 .

Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial.

N. Girard, C. Trépo, F. Mornex, 2006, International journal of radiation oncology, biology, physics.

[Doses to organs at risk in conformational and stereotactic body radiation therapy: Liver].

F. Mornex, G. Janoray, K. Debbi, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

IRIDIUM WIRE RADIOTHERAPY FOR HIGH BILEDUCT CARCINOMA

J. Gérard, F. Mornex, P. Bret, 1981, The Lancet.

Radiation therapy of pancreatic cancers.

F. Mornex, F. Huguet, I. Bessières, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.

L. Collette, V. Budach, K. Haustermans, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Whole brain radiation therapy for brain metastases: Advantages and controversies].

F. Mornex, P. Verrelle, F. Dhermain, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique].

I. Barillot, J. Ferlay, C. de Martel, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.

N. Girard, B. Milleron, J. Douillard, 2010, Lung cancer.

Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement.

J. Pignon, B. Milleron, D. de Ruysscher, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy for primary lung cancer.

F. Mornex, D. Lerouge, J. Darréon, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Late effects of radiations on mature and growing bone].

J. Bourhis, F. Mornex, O. Ramuz, 1997, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management.

N. Girard, M. Brevet, P. Souquet, 2019, Joint, bone, spine : revue du rhumatisme.

[Percutaneous vertebroplasty in the treatment of metastases. Technic and results].

P. Biron, F. Mornex, P. Thiesse, 1989, Journal de radiologie.

Hypofractionation in Early Stage Non-Small Cell Lung Cancer.

F. Mornex, A. Wrona, 2021, Seminars in radiation oncology.

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.

J. Daurès, P. Souquet, P. Fournel, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

N. Girard, A. Stenzinger, C. Swanton, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy for Locally Advanced Nonsmall Cell Lung Cancer Including Combined Modality

H. Choy, P. Houtte, K. Kubota, 2018 .

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)

Maximilien Vermandel, Pierre Vera, Bernard Dubray, 2017, The Journal of Nuclear Medicine.

Lymph Node Dissection in Thymoma: Is it worth it?

N. Girard, F. Mornex, S. Collaud, 2021, Lung cancer.

[Reference bases of radiotherapy under stereotaxic conditions for bronchopulmonary, hepatic, prostatic, upper aero-digestive, cerebral and bone tumors or metastases].

I. Barillot, P. Giraud, T. Lacornerie, 2018, Cancer Radiothérapie.

[The role of whole brain radiation therapy for brain metastases].

F. Mornex, G. Noël, D. Antoni, 2013, Bulletin du Cancer.

[How to treat brain metastasis in 2012?].

W. Jacot, F. Mornex, P. Metellus, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review.

N. Girard, M. Ychou, J. Scoazec, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.

D. Cowen, P. Rambert, F. Mornex, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Place of surgery in brain metastases].

Jacques Guyotat, Luc Bauchet, Philippe Menei, 2013, Bulletin du cancer.

Ocular and Orbital Tumors: Viewpoint-Fractionated Radiation

N. Girard, A. Vighetto, F. Mornex, 2015 .

Radiation therapy for malignant astrocytomas in adults.

F. Mornex, L. Taillandier, H. Nayel, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.

M. Piérart, M. van Glabbeke, R. Mirimanoff, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone Metastasis of Glioblastoma Multiforme Confirmed by Fine Needle Biopsy

D. Frappaz, A. Jouvet, C. Chassagne‐Clément, 1999, Acta Neurochirurgica.

Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer

E. Raymond, J. Kinet, P. Rougier, 2010, Cancer Chemotherapy and Pharmacology.

Is the treatment of hepatocellular carcinoma on the waiting list necessary?

N. Girard, R. Lencioni, R. Poon, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[Immunotherapy and radiotherapy].

F. Mornex, S. Bockel, D. Antoni, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Treatment, outcome, and prognostic factors in non-metastatic anal cancer: the French nationwide cohort study FFCD-ANABASE.

L. Quéro, A. Lièvre, C. Lepage, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.

N. Girard, M. Ychou, M. Ducreux, 2006, International journal of radiation oncology, biology, physics.

FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)

Pierre Vera, Bernard Dubray, Pierre Olivier, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting

L. Gaspar, D. Palma, A. Munshi, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.

N. Girard, P. Souquet, F. Mornex, 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Respiratory Gating Techniques for Optimization of Lung Cancer Radiotherapy

Philippe Giraud, Marie-Odile Carrère, Magali Morelle, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Endocavitary radiation therapy

P. Romestaing, J. Gérard, F. Mornex, 1998 .

Sphincter preservation in rectal cancer. Endocavitary radiation therapy.

P. Romestaing, J. Gérard, F. Mornex, 1998, Seminars in radiation oncology.

The role of radiotherapy in the conservative treatment of rectal carcinoma--the Lyon experience.

P. Romestaing, J. Gérard, F. Mornex, 1998, Acta oncologica.

[Platinum salts hypersensitivity].

C. Rioufol, F. Mornex, S. Couraud, 2008, Revue de pneumologie clinique.

113Late effects of normal tissues (LENT) scoring system: The SOMA scale

J. Denekamp, F. Mornex, Pavy Jj, 1996 .

Reply to R. Glynne-Jones et al.

T. Conroy, M. Ducreux, D. Peiffert, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients.

P. Romestaing, J. Gérard, F. Mornex, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer.

P. Romestaing, J. Gérard, F. Mornex, 2005, International journal of radiation oncology, biology, physics.

PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy.

N. Girard, S. Peters, R. Fietkau, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy for locally advanced non-small cell lung cancer.

N. Girard, F. Mornex, 2009, European journal of cancer.

A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemo-radiotherapy in locally advanced non small cell lung cancer (NSCLC). Interim analysis of toxicity. (GLOT-GFPC NPC 95-01 study)

J. Daurès, P. Souquet, P. Fournel, 2000 .

Radiotherapy of the pancreas: state of the art in 2012.

F. Mornex, G. Pigné, C. Enăchescu, 2012, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

1171MO PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

N. Girard, S. Peters, R. Fietkau, 2021, Annals of Oncology.

Etoposide sensitivity of radioresistant human glioma cell lines

F. Mornex, J. Doré, J. Bonner, 1997, Cancer Chemotherapy and Pharmacology.

Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study.

J. Bosset, P. Maingon, C. Borg, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Joint statement of mission by the RTOG/EORTC working groups

H. Bartelink, J. Horiot, T. Phillips, 1995 .

Long-Term Survival (5Y20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma

D. Jaeck, J. Scoazec, J. Mosnier, 2008 .

Induction treatment before surgery for non-small cell lung cancer.

R. Mirimanoff, J. Pignon, A. Gregor, 2003, Lung cancer.

MALIGNANT LYMPHOMAS IN THE FRENCH WEST INDIES

F. Mornex, J. Mornex, H. Azaloux, 1982, The Lancet.

Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art.

N. Girard, F. Mornex, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes.

Patrice Jalade, Olivier Chapet, P. Romestaing, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Single French centre retrospective analysis of local control after high dose radiotherapy with or without chemotherapy and local control for Pancoast tumours].

B. De Bari, P. Souquet, F. Mornex, 2012, Cancer Radiothérapie.

EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale.

H. Bartelink, J. Horiot, M. Bolla, 1995, Radiotherapy and Oncology.

[Local excision and adjuvant radiotherapy for rectal adenocarcinoma T1-2 N0].

P. Romestaing, J. Gérard, F. Mornex, 2000, Gastroenterologie clinique et biologique.

Role of radiotherapy in the treatment of invasive lymphoepithelial thymomas. A multicentric retrospective review of 89 cases

P. Rambert, F. Mornex, X. Mirabel, 1993 .

Use of monoclonal antibodies as radiopharmaceuticals for the localization of human carcinoma xenografts in athymic mice.

F. Mornex, D. Colcher, J. Esteban, 1986, Methods in enzymology.

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiation after curative resection for pancreatic cancer: Updated results of a randomized EORTC/FFCD/GERCOR phase II study (40013-22012/9203).

V. Budach, K. Haustermans, E. Van Cutsem, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral tyrosine kinase inhibitor masitinib in combination with gemcitabine in patients with advanced pancreatic cancer: A multicenter phase II study.

E. Raymond, P. Rougier, G. Deplanque, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Chemoradiation for locally advanced non-small cell lung cancer].

N. Girard, F. Mornex, 2007, Cancer Radiothérapie.

79MO PACIFIC-R: Real-world characteristics of unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

N. Girard, S. Siva, A. Allen, 2021 .

Curative treatment of carcinoma of the prostate with an association of external irradiation, iridium implant and lymphadenectomy.

P. Romestaing, J. Gérard, F. Mornex, 1987, Progress in clinical and biological research.

Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen.

F. Mornex, J. Mabrut, P. Merle, 2023, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].

P. Romestaing, J. Gérard, F. Mornex, 1997, Bulletin du cancer.

TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial

A. Luciani, C. Féray, L. Mineur, 2023, JHEP reports : innovation in hepatology.

A randomized trial comparing TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma

A. Luciani, C. Féray, L. Mineur, 2023, JHEP Reports.

Surgical resection versus transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma

F. Mornex, J. Mabrut, P. Merle, 2022, Strahlentherapie und Onkologie.

Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.

N. Girard, B. Chauffert, M. Ychou, 2010, International journal of radiation oncology, biology, physics.

Syndrome de Garcin associé à un cancer de poumon

F. Mornex, O. Chapet, Z. Youbi, 2017 .

[Adaptive radiation therapy for non-small cell lung cancer].

N. Paragios, J. Bibault, P. Giraud, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Is There a Role for Postoperative Radiotherapy in Elderly Patients with Early-Stage Non-small Cell Lung Cancer?

N. Girard, F. Mornex, 2013 .

[Radiotherapy for primary lung carcinoma].

P. Giraud, T. Lacornerie, F. Mornex, 2016, Cancer Radiothérapie.

Clinical and radiological aspects of Villaret's syndrome

G. Aimard, F. Mornex, P. Petiot, 1996, Clinical Neurology and Neurosurgery.

[Improvements of ablative local treatments modify the management of the oligometastatic disease].

J. Thariat, F. Mornex, R. Bensadoun, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Stage IIIB non-small cell lung cancer. Optimization of radiotherapy in lung cancer: some interesting questions to be solved].

N. Girard, F. Mornex, 2006, Revue des maladies respiratoires.

[Radiotherapy of thymoma. Study of the literature apropos of a retrospective and multicenter series of 149 cases].

P. Rambert, F. Mornex, X. Mirabel, 1995, Bulletin du Cancer/Radiothérapie.

Development of an intracerebral glioma model in whole body irradiated hairless rats.

F. Mornex, J. Doré, J. Brunon, 2000, Anticancer research.

[Radiotherapy of cancer of the anal canal. 15 years experience at the Lyon civil hospices and brief review of the literature].

E. Morignat, P. Romestaing, J. Gérard, 1998, Annales de Chirurgie.

Characterization of double minute chromosomes’ DNA content in a human high grade astrocytoma cell line by using comparative genomic hybridization and fluorescence in situ hybridization

T. Cremer, T. Ried, F. Mornex, 1996, Human Genetics.

Conformal radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: is it safe?

F. Mornex, J. Mabrut, S. Ledochowski, 2016, Future oncology.

[Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial].

N. Girard, C. Trépo, F. Mornex, 2005, Cancer Radiothérapie.

[Task sharing with radiotherapy technicians in image-guided radiotherapy].

F. Mornex, F. Lorchel, O. Diaz, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Stereotactic body radiation therapy (SBRT) in the treatment of liver metastases: state of the art].

B. De Bari, F. Mornex, M. Guillet, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.

T. Conroy, M. Ducreux, D. Peiffert, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.

F. Mornex, P. Souquet, A. Bellière, 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study

G. Mishra, F. Mornex, C. Partensky, 2006, British Journal of Cancer.

[Late effects of ionizing radiations on normal tissues].

M. Bolla, F. Mornex, J. Mazeron, 1997, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Combination of stereotactic irradiation and chemotherapy or targeted therapies: state of the art and preliminary recommendations].

J. Thariat, G. Milano, F. Mornex, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting

L. Gaspar, D. Palma, A. Munshi, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.